WO1998021356A1 - Enzyme sensor - Google Patents

Enzyme sensor Download PDF

Info

Publication number
WO1998021356A1
WO1998021356A1 PCT/DK1997/000508 DK9700508W WO9821356A1 WO 1998021356 A1 WO1998021356 A1 WO 1998021356A1 DK 9700508 W DK9700508 W DK 9700508W WO 9821356 A1 WO9821356 A1 WO 9821356A1
Authority
WO
WIPO (PCT)
Prior art keywords
enzyme
immobilised
sensor
membrane
analyte
Prior art date
Application number
PCT/DK1997/000508
Other languages
French (fr)
Inventor
Thomas Ahl
Allan Milton Byrnard
Original Assignee
Radiometer Medical A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radiometer Medical A/S filed Critical Radiometer Medical A/S
Priority to JP10522060A priority Critical patent/JP2000507457A/en
Priority to US09/308,212 priority patent/US6051389A/en
Priority to DE69735127T priority patent/DE69735127T2/en
Priority to EP97912066A priority patent/EP0944731B1/en
Publication of WO1998021356A1 publication Critical patent/WO1998021356A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/002Electrode membranes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/963Methods of stopping an enzyme reaction or stabilizing the test materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/973Simultaneous determination of more than one analyte

Definitions

  • the present invention relates to an enzyme sensor for measuring the concentration or activity of an analyte in a test fluid and to a membrane for an enzyme sensor, which have been improved with respect to initial specific enzymatic activity.
  • the present invention also relates to a method for improving the enzymatic stability (the lifetime) of enzyme sensors in general .
  • Enzyme sensors are sensors where a chemical species to be measured (an analyte) undergoes an enzyme catalysed reaction in the sensor before detection.
  • the reaction between the analyte and the enzyme yields a secondary species which concentration (under ideal conditions) is proportional with or identical to the concentration of the analyte.
  • concentration of the secondary species is then detected by a transducer, e.g., by means of an electrode .
  • the enzyme of an enzyme sensor is typically included in a membrane suited for contacting the test fluid.
  • the enzyme may be included as part of a membrane of a sensor or may be located behind such a membrane.
  • Another alternative is to incorporate the enzyme into the sensor proper, e.g. as part of a carbon paste layer of an electrode.
  • the analyte is contacted with the enzyme after diffusion into the outer part of the sensor (e.g. the membrane or the carbon paste layer), the en- zyme/analyte reaction takes place, and the secondary species then diffuses to the detector part of the sensor, e.g. an electrode.
  • the membrane In a traditional enzyme sensor comprising a membrane, the membrane must, on the one hand, have a suitable porosity so that the analyte diffuses from the test fluid to the enzyme in a controlled manner, and, on the other hand, be impermeable or substantially impermeable to the enzyme in question in order to avoid leaching of the enzyme into the test fluid.
  • lactate sensors wherein lactate oxidase is immobilised to bovine serum albumin are known (Hu et al . , 1993, Analytica Chimica Acta, 281, pp 503-511; Tsuchida et al . , 1985, Biotech- nology and Bioengineering, 27, pp 837-841; Pfeiffer et al., 1992, Biosensors & Bioelectronics, 7, pp 661-671; Baker et al . , 1995, Anal.
  • the initial specific enzymatic activity of the immobilised enzyme is reduced compared to a corresponding amount of non-immobilised enzyme.
  • the enzyme, or at least a part (a domain) thereof does not retain its active conforma- tion during or after the immobilisation reaction, or that the immobilisation reaction involves functional groups of the enzyme which are situated in or very close to the active site of the enzyme.
  • a considerable amount of enzyme may be inactivated in the immo- bilisation reaction.
  • the presence of large amounts of inactivated, partially inactivated or denatured enzyme in a sensor is highly undesirable as this may lead to longer response times.
  • the aim of the present invention is to provide enzyme sensors which have an improved initial specific enzymatic activity.
  • Another aim of the present invention is to provide a method for stabilising the enzymatic ac- tivity of enzyme sensors so that the lifetime of enzyme sensors can be prolonged.
  • the present invention provides an enzyme sensor for measuring the concentration or activity of an analyte of a test fluid, the sensor having at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the immobilised enzyme being obtained by formation of one or more covalent link(s), optionally by using a cross-linking agent, between the enzyme and at least one type of macromolecule in the presence of a competitive inhibitor for said enzyme .
  • the enzyme layer may be applied to the sensor in vari ⁇ ous ways.
  • the enzyme layer may be included as part of a membrane of a sensor or may be located behind such a membrane.
  • the enzyme layer may be an integral part of the sensor, e.g. included in a car- bon paste layer of an electrode.
  • the enzyme layer is included in a membrane to be mounted to the sensor.
  • the present invention also provides a membrane for an enzyme sensor for measuring the concentration or activity of an analyte in a test fluid, said membrane having an enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the immobilised enzyme being obtained by formation of one or more cova- lent link(s), optionally by using a cross-linking agent, between the enzyme and at least one type of mac- romolecule in the presence of a competitive inhibitor for said enzyme.
  • enzyme sensors and membranes prepared as defined above result in enzyme sensors and membranes having hitherto unsurpassed high initial specific enzymatic activities compared to conventionally prepared sensors and membranes.
  • the present invention further provides an enzyme sensor for measuring the concentration or activity of an analyte of a test fluid, the sensor having at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the initial specific enzymatic activity of the immobilised enzyme being at least 50% of the initial specific enzymatic activity of a corresponding amount of non-immobilised enzyme, determined in the same test.
  • the enzyme may be applied to the sensor as described above .
  • the present invention provides a membrane for an enzyme sensor for measuring the concentration or ac- tivity of an analyte of a test fluid, said membrane having at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the initial specific enzymatic activity of the immobilised enzyme being at least 50% of the initial specific enzymatic activity of a corresponding amount of non- immobilised enzyme.
  • the present invention also provides a method for improving the stability of the enzymatic activity of an immobilised enzyme included in an enzyme sensor, comprising intermittently or continuously exposing the immobilised enzyme to a solution comprising a competitive inhibitor for said enzyme.
  • the improved stability is obtained both for an enzyme sensor with an immobilised enzyme obtained by formation of covalent link(s) between the enzyme and a macromole- cule in the presence of a competitive inhibitor for the enzyme and for an enzyme sensor with an immobilised enzyme obtained as above, but in the absence of a competitive inhibitor, as well as for any other enzyme sensor with an immobilised enzyme.
  • the present invention provides novel and highly valuable enzyme sensors and membranes for enzyme sensors. Enzyme sensors have become increasingly important for analytical purposes in that it is desirable, as a matter of routine, to analyse a large number of test fluids with respect to the concentration (or activity) by using fully automatic apparatuses.
  • ABLTM System 625 Blood Gas System (Radiometer Medical A/S, Copenhagen, Denmark)
  • Such a system is, from the user's side, expected to allow for long operating times ("up” time) and very short and rare service times (“down” time) .
  • enzyme sensors used in such apparatuses should have a long lifetime.
  • the present invention provides long-life enzyme layers for enzyme sensors.
  • the analyte to be measured by the enzyme sensor may be any substance which is a substrate for an enzyme which can be included in the membrane of a sensor.
  • Especially interesting analytes in the present context are glucose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglycerides, phenylalanine, tyrosine, and hypoxanthine .
  • An especially relevant analyte in the present context is lactate.
  • Other analytes that might be interesting to measure are glycated amino acids, coagulation factors and sepsis markers.
  • the selection of a relevant enzyme for a sensor is naturally directed by the analyte. It should also be considered that one of the reaction product (s) of the enzyme/analyte reaction (the secondary species) must be detectable either directly or after subsequent conver- sion into a detectable substance.
  • a preferred secondary species is hydrogen peroxide which may be detected by conventional electrodes.
  • preferred enzymes in the present context are those for which an analyte selected from the group consisting of glucose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglyce- rides, phenylalanine, tyrosine, and hypoxanthine is a substrate .
  • an analyte selected from the group consisting of glucose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglyce- rides, phenylalanine, tyrosine, and hypoxanthine is a substrate .
  • Particularly interesting enzymes are selected from the group consisting of ⁇ -hydroxy oxidase (E . C .1.1.3.15) , lactate oxidase (E . C .1.1.3.2. ) , glucose oxidase
  • test fluid is intended to mean any liquid comprising an analyte which concentration or activity it is desirable to measure.
  • the test fluid is an aqueous test fluid, e.g. a test fluid of natural origin.
  • a test fluid of natural origin e.g. a test fluid of natural origin.
  • biological samples from animals or humans, especially from humans .
  • biological samples may ei- ther be used directly or they may be diluted or treated in various ways in order to remove species which would otherwise interfere with the enzyme, the detector, or the analyte.
  • biological samples are whole blood, e.g. diluted or undiluted whole blood, blood plasma, blood serum, cerebrospinal fluid, synovial fluid, urine, saliva, and milk.
  • Other interesting test fluids are e.g. dialysis fluids.
  • the present invention takes advantage of competitive inhibitors in immobilisation reactions and subsequently as stabilising agent.
  • a competitive inhibitor when covalent links between an enzyme and (a) macromolecule (s) are formed, eliminates or reduces the risk of chemical functionalities in the active site of the enzyme (the site to which a substrate for the enzyme is bound when the enzymatic action is expressed) taking part in the covalent link formation reaction.
  • chemical functionalities in the active site e.g. amino and guanidino groups of lysines and arginines, respectively, may be involved in the covalent bond formation reaction whereby the enzyme activity is reduced or eliminated.
  • a competitive inhibitor for a specific enzyme is characterised in that it binds in, or in the close proximity of, the active site of the enzyme so that a sub- strate for the enzyme is obstructed from immediately occupying the active site.
  • affinity for the enzyme in question
  • concentration of the competitive inhibitor in relation to the affinity (for the enzyme in question) and concentration of the substrate, there will be a competition (cf. "competitive") between the inhibitor and the substrate for occupation of the active site.
  • Suitable competitive inhibitors may be any of the com- petitive inhibitors for the enzyme in question known in the art.
  • "partial" competitive inhibitors are to be construed as competitive inhibitors in the present context.
  • competitive inhibitors especially relevant in the present context are those which, on the one hand, binds efficiently to the enzyme in question during the immobilisation reaction and, on the other hand, can be replaced by the substrate (the analyte) for the enzyme in question when the immobilised enzyme is included in the enzyme sen- sor.
  • especially suitable competitive inhibitors are those which have an affinity (1/K X ) for the enzyme in question which is about 0.0001 to 10 times, such as 0.001 to 5 times, the affinity of the substrate for the same enzyme.
  • preferred competitive inhibitors are selected from the group consisting of oxalacetate, oxalate, ⁇ -hydroxy-sulphonate, bisulphite, and phenylacetate . Oxalate has proved to be especially preferred.
  • any coenzymes necessary for the enzyme to exhibit enzymatic activity is present during the immobilisation reaction so that (i) the immobilisation reaction is performed when the enzyme is present in an active conformation and (ii) the site to which the coenzyme is attached is not blocked by cova- lent links to the macromolecule (s) .
  • macromolecule is to be understood as a high molecular weight molecule, which may be the enzyme proper.
  • the macromolecule should have a chemical functionality which allows for the formation of covalent bonds between the macromolecule and the enzyme in question. It should be understood that the macromolecule may be of natural origin as well as synthetic origin (e.g. a synthetic organic polymer) .
  • proteins e.g. albumins and albumin derivatives, such as serum albumin (e.g. bovine serum albumin and bovine se- rum albumin-cysteinyl) , conalbumin (ovotransferrin) , ovalbumin (egg white albumin) , lactalbumin, grain albumin, and soybean albumin.
  • serum albumin e.g. bovine serum albumin and bovine se- rum albumin-cysteinyl
  • conalbumin ovotransferrin
  • ovalbumin egg white albumin
  • lactalbumin e.g. lactalbumin, grain albumin, and soybean albumin.
  • macromolecules of synthetic origin are polymeric compounds such as polyolefins and derivatives thereof, e.g. polyethylene, polypropylene, polystyrene, and poly (meth) acrylate, polyester, polyethers, polyal- kylene glycols, e.g. polyethylene glycol, polypropylene glycol, and polybutylene glycol, polyamides, and syn- thetic polypeptides, dextrans, and proteins.
  • macromolecules selected from the group consisting of albumins and albumin derivatives, such as bovine serum albumin, bovine serum albumin-cysteinyl, conalbumin (ovotrans- ferrin) , and ovalbumin (egg white albumin) , are especially preferred.
  • the weight average molecular weight of macromolecules particularly relevant in connection with immobilising of enzymes is from 10,000, such as from 10,000 to 1,000,000, preferably 10,000 to 200,000, in particular 20,000 to 100,000.
  • the immobilisation reaction may be performed either by direct reaction between the enzyme and the macromolecule or by using a cross- linking agent. Usually a cross-linking agent is required.
  • Cross-linking agents are known to the person skilled in the art, however, especially preferred cross-linking agents for the enzymes described herein are selected from the group consisting of glutaralde- hyde, divinyl sulphone, cyanuric chloride, diisocy- anates, polyisocyanates, diisothiocyanates, and poly- isothiocyanates, among which glutaraldehyde is preferred.
  • the degree of cross-linking should be so that, on the one hand, leaching of the immobilised enzyme is avoided and, on the other hand, the mobility of the various domains of the enzyme is maintained (otherwise the enzymatic activity will be hampered) . It is believed that a weight average molecular weight of the enzyme/macro- molecule conjugate (the immobilised enzyme) should be at least 100,000, preferably in the range of 100,000 to 5,000,000, in particular 200,000 to 4,000,000, in order for the immobilised enzyme to become unable or substantially unable to diffuse through the outer layer of an enzyme sensor, e.g. a diffusion limiting layer (see further below) , and at the same time be sufficiently soluble or dispersible in an aqueous medium, e.g. a buffer, so that handling is possible prior to inclusion in a membrane.
  • an enzyme sensor e.g. a diffusion limiting layer (see further below)
  • the immobilised enzymes are preferably prepared as follows: (a) a solution comprising the enzyme, at least one type of macromolecules, and a competitive inhibitor for said enzyme is prepared; and (b) a cross-lmkmg agent is added to the solution. Furthermore, (c) a quenching reagent may be added after the desired reaction time in order to inactivate any remaining cross- linking agent and effectively terminate the reaction. Quenching reagents are reagents which react with the cross-lmkmg agent or any intermediate derived from the cross-lmkmg agent.
  • the cross-lmkmg reaction should preferably take place at a temperature the range of 0-40°C, more prefera- bly m the range of 10-30°C, so that the enzyme is not denatured during the cross-lmkmg reaction.
  • the cross-lmkmg reaction is performed at ambient temperature .
  • an aqueous medium is preferred over an organic media.
  • the aqueous medium should preferably be a buffer adjusted to the a pH value the range of 5.0-9.0, in particular m the range of 6.0-8.0. Phosphate buffers are especially preferred.
  • immobilised lactate oxidase for the sensor is prepared from 4-7 parts by weight, such as 5-6 parts by weight, of lac- tate oxidase, 8-12 parts by weight, such as 9-11 parts by weight, of bovine serum albumin-cysteinyl, and 1.5- 3.5 parts by weight, such as 2-3 parts by weight, of cross-linking agent using 12-15 parts by weight, such as 13-14 parts by weight, of sodium oxalate (see Exam- pie 1) .
  • the enzyme of an enzyme sensor is typically included in a membrane suited for contacting the test fluid.
  • the membranes according to the invention are preferably membranes comprising an enzyme layer included as part of a membrane or located behind such a membrane.
  • the membrane may serve several purposes including providing protection from potentially harmful substances in the test fluid, ascertaining retention of the enzyme in the membrane and providing optimal diffusion limiting conditions for the analyte to be measured in order to obtain sufficient linearity for the sensor.
  • the membranes comprise a diffusion limiting layer which is adapted to separate the enzyme layer and the test fluid.
  • the diffusion limiting layer is a porous membrane layer which limits the diffusion of the analyte into the enzyme layer so that the capacity of the immobilised enzyme for conversion of the analyte is not exceeded, and so that sufficient 0 2 for the enzymatic conversion of the analyte is present in the enzyme layer.
  • the principle of diffusion limiting layers is described in Danish Patent No. 170103.
  • the diffusion limiting layer may consist of a membrane of a type normally used for sensors. These comprise solution/diffusion type membranes (e.g. hydrogels), track etch membranes (having straight pores), composite membranes and tortuous path membranes.
  • solution/diffusion type membranes e.g. hydrogels
  • track etch membranes having straight pores
  • composite membranes e.g. composite membranes
  • tortuous path membranes e.g. hydrogels
  • the material for the diffusion limiting layer may include any membrane material for sensors known in the art.
  • membrane material for sensors known in the art.
  • examples are polyolefins and derivatives thereof, e.g. polyethylene, polypropylene, polystyrene, and poly (meth) acrylate, polyester, polyethers, polyalkylene glycols, e.g. polyethylene glycol, polypropylene gly ⁇ col, and polybutylene glycol, polyamides, silicones and regenerated cellulose.
  • Polyesters such as polyethylene terephthalate may be especially suitable.
  • Other polymers such as e.g. polycarbonates and polyurethanes may be useful as well.
  • the diffusion limiting layer has through-going pores which are permeable to the analyte and impermeable or substantially impermeable to the immobilised enzyme, and at least a part of the pores should, of course, extend from the surface of the diffusion limiting layer adapted to face the test fluid to the surface of the diffusion limiting layer adapted to face the enzyme layer.
  • the through-going pores of the diffusion limiting layer have walls, and that the surface of these walls together with the surface adapted to face the test fluid define an accessible surface of the diffusion limiting layer, i.e. the surface accessible to the test fluid.
  • This accessible sur- face of the diffusion limiting layer should preferably be hydrophilic so that, e.g., blood proteins do not become attached to the surface.
  • the accessible surface of the diffusion limiting layer may, if it is not in itself sufficiently hydrophilic, have derivatisable chemical groups of which at least a part are deriva- tised with a hydrophilic component whereby the accessible surface is rendered more hydrophilic than a corresponding non-derivatised surface.
  • the derivatisable chemical groups may be present in the natural form of the membrane layer material, or they may arise after treatment of the membrane layer material with a chemical reagent, or after irradiation of the membrane .
  • the hydrophilic component should be selected so that the surface treated membrane layer is not degraded under the normal cleaning and rinse conditions applicable for enzyme sensors.
  • polyal- kylene glycols such as polyethylene glycol (PEG) , hepa- rin, hyaluronic acid, phospholipids, agarose, chitosan, cyclodextrin, alginate, collagen, lignin, pectin as well as polysaccharides and cellulose-based polymers such as dextrin, hydroxyalkylcelluloses, cellulose ace- tates, albumin, gelatine, agar, carageenans, and starch are suited as hydrophilic components.
  • hydrophilic synthetic organic polymers e.g. polyvinylalcohol/poly- vinylacetates, polyvinylpyrrolidone, hydroxyalkyl- (meth) acrylates such as hydroxymethyl (meth) acrylate and hydroxyethyl (meth) acrylate, (meth) acrylic acid, allyl- alcohol, and acrylpolymers (hydrogels) may be used.
  • polyethylene glycol and heparin are especially interesting. Furthermore, polyethylene glycols having an average molecular weight of from about 100 to about 2000, such as from about 200 to about 1000, are believed to be especially relevant as hydrophilic components.
  • the membrane according to the invention may further comprise an interference eliminating layer which is permeable to the product from the enzyme/analyte reaction and impermeable or substantially impermeable to the analyte and the immobilised enzyme.
  • the interference eliminating layer should preferably also be impermeable to other chemical components which may be present in the test fluid.
  • a very suitable material, which is impermeable to, e.g., HEPES, ascorbic acid, and paracetamol and permeable to, e.g., H 2 0 2 is cellulose acetate .
  • the membrane comprises:
  • a diffusion limiting layer comprising polyethylene terephthalate, the accessible surface of the diffusion limiting layer having carboxyl groups, at least a part of these carboxyl groups being derivatised by cova- lently linking thereto polyethylene glycol having an average molecular weight in the range of 100-1000;
  • the individual membrane layers are cut in congruent pieces and are assembled, e.g., in a membrane ring.
  • the membrane preferably has a thickness in the range of 10- 50 ⁇ m, in particular in the range of 10-30 ⁇ m.
  • the diffusion limiting porous membrane layer is preferably 5- 20 ⁇ m
  • the enzyme layer is preferably 1-3 ⁇ m
  • the interference limiting layer is preferably 5-10 ⁇ m.
  • the sensor according to the present invention may be based on one or several applicable detector principles, such as electrochemical or optical principles.
  • the detector part face of the sensor may, e.g., be a part of an electrode or an optical detector.
  • the detector part of the sensor is a part of an electrode .
  • An electrode may comprise an anode of e.g. carbon paste or platinum, gold, iridium, rhodium, palladium and al ⁇ loys or pastes thereof, and a reference electrode of e.g. silver/silver chloride, silver/silver oxide, or mercury/mercury (I) chloride.
  • the electrode may further comprise any necessary electrolyte solution.
  • the electrode comprises a platinum anode and silver/silver chloride reference electrode.
  • the initial specific enzymatic activity of the immobilised enzyme included in a membrane for an enzyme sensor is at least 50% of the initial specific enzymatic activity of a corresponding amount of non- immobilised enzyme.
  • the initial specific enzymatic activity is at least
  • Example 4 the initial specific enzymatic activity for immobilised lactate oxidase is 78% (Table 1) .
  • immobilised lactate oxidase prepared as described in Example 4 will, when incorporated in a membrane for an enzyme sensor, constitute a preferred embodiment of the present invention.
  • the initial specific enzymatic activity of the immobilised enzyme is at least 1.5 times the initial specific enzymatic activity of a corresponding amount of enzyme immobilised to the same kind of macromolecule by using, if applicable, the same kind of cross-linking agent in the absence of a competitive inhibitor for said enzyme.
  • immobilised lactate oxidase fulfils this criteria, cf. Table 1.
  • the present invention provides enzyme sensors and membranes for en- zyme sensors which may be designed so that they have an hitherto unsurpassed lifetime.
  • the initial specific enzymatic activity is higher than when using conven- tional conditions, and, consequently, the period before the enzymatic activity reaches the level where the sensor becomes unusable is prolonged.
  • the ap- plicant has found that storage of enzymes in a medium comprising a competitive inhibitor for the enzyme improves the stability of the enzymatic activity (see Example 5) .
  • the present invention provides a method for improving the stability of the enzymatic activity of an immobilised enzyme included in an enzyme sensor for measuring the concentration of an analyte in a test fluid, the analyte being a substrate for the enzyme, the method comprising intermittently or continuously exposing the immobilised en- zyme to a solution comprising a competitive inhibitor for said enzyme.
  • the immobilised enzyme may be included as an integral part of the sensor, or included in a membrane of the enzyme sensor.
  • the present invention also provides a method for improving the stability of the enzy- matic activity of an immobilised enzyme included in a membrane for an enzyme sensor.
  • the enzyme layer comprising the immobilised enzyme is exposed to a solution comprising a competitive inhibitor for said enzyme between each or substantially each measurement, or between each or substantially each series of measurements, of the analyte.
  • the competitive in- hibitor may be included in the rinse fluid for said sensor .
  • the concentration of the competitive inhibitor in the rinse fluid should preferably be so that, when the en- zyme in question is permanently stored in the rinse fluid comprising the competitive inhibitor at that specific concentration, the increase in t ⁇ for the enzymatic activity would be at least 50%, such as at least 100%, in particular at least 200%.
  • ком ⁇ онентs which, on the one hand, have the ability to efficiently stabilise an enzyme composition, especially an immobilised enzyme composition, and, on the other hand, allow for the enzymatic reaction to take place in the (simultaneous) presence of a substrate for the enzyme, are those which have a binding affinity for the active site of the enzyme which is equal to, or slightly lower than, the binding affinity of the relevant substrate.
  • the method is performed for lactate oxidase included in an enzyme sensor for measuring lactate in a biological sample.
  • the present invention also relates to the use as a stabilising agent for an immobilised enzyme included in an enzyme sensor of a solution comprising a competitive inhibitor for said enzyme.
  • a solution may be a rinse or cleaning fluid for the sensor.
  • a solution comprising a competitive inhibitor may also be used for the stabilisation of non-immobilised enzymes or enzymes which have been immobilised in other ways than described herein.
  • the enzyme sensors and the membranes described herein are especially suited for use in fully automatic apparatuses for measuring the concentration or activity of one or more analytes in a test fluid.
  • fully automatic apparatuses it is possible, even with only minor reconstruction efforts or replacement of the rinse fluid (s) for the enzyme sensor (s), to utilise the method according to the inven- tion.
  • the present invention also provides an apparatus for measuring the concentration or activity of one or more analytes of a test fluid, the apparatus comprising an enzyme sensor having a layer of an immobilised enzyme for which at least one of the analytes is a substrate, wherein the apparatus further comprises one or more containers with solution (s) needed for the operation of the apparatus, at least one solution comprising a competitive inhibitor for the enzyme, and means for intermittently exposing the sensor to the solution comprising the competitive inhibitor.
  • Fig. 1 illustrates an enzyme sensor 1 comprising an electrode and a membrane
  • Fig. 2 illustrates in detail the membrane part of the membrane of Fig. 1, and
  • Fig. 3 illustrates in schematic form an embodiment of an apparatus according to the invention.
  • Fig. 1 shows an enzyme sensor 1 for measuring lactate. Enzyme catalysed reaction between lactate and oxygen yields hydrogen peroxide (H 2 0 2 ) and pyruvate. Hydrogen peroxide is then detected by an amperometric electrode.
  • the sensor 1 is suited for mounting in an apparatus for measuring the concentration of analytes in a biological sample, e.g. an ABLTM 625 Blood Gas System (Radiometer Medical A/S, Copenhagen, Denmark) .
  • the sensor 1 comprises an electrode 2 onto which a membrane ring 3 is attached.
  • the electrode 2 comprises a platinum anode 4 connected with a platinum wire 5, which, through a micro plug 6, is connected with an silver anode contact body 7.
  • the platinum anode 4 and the lower part of the platinum wire 5 is sealed into a glass body 8. Between the glass body 8 and the micro plug 6, the platinum wire 5 is protected with a heat shrink tubing.
  • a tubular silver reference elec- trode 10 encircles the upper part of the glass body 8 and extends in the length of the electrode 2 to the anode contact body 7, which is fastened inside the reference electrode by means of a fixing body 11 and epoxy 12.
  • the lower part of the glass body 8 is surrounded by an electrode base 13 whereto the membrane ring 3 is attached.
  • the upper part of the reference electrode 10 is surrounded by a plug part 14 for mounting the electrode 2 in the corresponding plug of an analysis apparatus (not shown) and for fixing a mantle 15. Gaskets 16 and 17 are placed between the electrode 2 and the mantle 15 in order to ensure that any electrolyte located at the measuring surface of the electrode 2 does not evapo- rate.
  • the membrane ring 3, which is mounted at one end of the mantle 15, comprises a ring 20.
  • a membrane 21 is stretched over the lower opening of the ring 20. This membrane 21 is shown in detail in Figure 2.
  • Fig. 2 shows a membrane 21 comprising three layers: an interference limiting membrane layer 22 facing the platinum anode 4 of the electrode 2, an enzyme layer 23, and a diffusion limiting porous membrane layer 24 facing the test fluid.
  • the interference limiting mem- brane layer 22 may be a 6 ⁇ 2 ⁇ m porous membrane of cellulose acetate (CA) .
  • the enzyme layer is typically an approx. 1-2 ⁇ m layer of cross-linked lactate oxidase (7 units/membrane).
  • the diffusion limiting porous membrane layer 24 may be an approx. 10 ⁇ m layer of poly- ethylenetherephthalate (PETP) (pore diameter approx. 0.1 ⁇ m; pore density: 8-10 5 pores/cm 2 ).
  • PETP poly- ethylenetherephthalate
  • Fig. 3 shows in schematic form an embodiment of an apparatus 30 according to the invention.
  • the apparatus 30 comprises several sensors 1, 31-36 for measuring the concentration or activity of different analytes in a test fluid.
  • the sensors include a reference electrode 31, sensors for measuring e.g. pH, p0 2 , p0 2 , etc. 32-36 and an enzyme sensor 1 for measuring lactate similar to the sensor described above in connection with Figs. 1 and 2.
  • the sensors 1, 31-36 are located in a measuring section shown by the dotted line 38.
  • the apparatus 30 has an inlet 40 for introduction of a test fluid into the apparatus 30 and several containers 50-54 with solutions needed for the operation of the apparatus 30.
  • the container 50 comprises a salt- bridge solution for the reference electrode 31
  • the containers 51 and 53 comprise different calibration so- lutions for the sensors 1, 32-36
  • the container 52 comprises a cleaning solution for the sensors 1, 32-36
  • the container 54 comprises a rinse solution for the sensors 32-36.
  • the rinse solution of the container 54 comprises oxalate which as mentioned previously is a competitive inhibitor for the lactate oxidase enzyme in the lactate enzyme sensor 1.
  • the apparatus 30 further includes a waste container 55 and air inlets 56, 57.
  • a fluid conduit system (shown in dark lines) connects the inlet 40, the containers 50-55 and the air inlets 56, 57 with the sensors 1, 31-36. Test fluid from the inlet, solutions from the different containers 50-54 and optionally air from the air inlets 56, 57 may be transferred in the fluid conduit system by means of pumps 61, 62 and a main valve 63 controlled by not shown software means of the apparatus 30.
  • the pumps 61, 62 and the main valve 63 are activated to transfer the test fluid to the measuring section 28 and the test fluid is analysed. Then the test fluid is transferred to the waste container 55.
  • a rinse operation is now performed comprising activating the pumps 61, 62 and main valve 63 to transfer rinse fluid from the container 54 through the fluid conduit system to the sensors 1, 31-36 in the measuring section 28 and thence to the waste container 55.
  • the lactate enzyme sensor 1 is exposed to the oxalate contained in the rinse fluid.
  • the lactate enzyme sensor 1 included in the apparatus 30 will be frequently exposed to the competitive inhibitor oxalate as this takes place in between each measurement performed on the apparatus 30.
  • Lactate oxidase catalyses the reaction:
  • quinonimine dye Assay system where a quinonimine dye is formed.
  • the amount of formed quinonimine dye is determined spectrophotometically at 490 nm.
  • Enzyme Solution (enzyme composition to be tested) :
  • a microtiter- plate ( Immunoplate, Nunc, Roskilde, Denmark) .
  • the col- our reaction is started by adding 100 ⁇ L of the Enzyme Solution.
  • the microtiterplate is placed in the plate-holder of a THERMOmax incubator (Molecular Devices, Menlo Park, CA, USA) pre-set to: 37°C, kinetic mode, lag-time 5 min., reading time 15 min., and automix.
  • Enzyme Solution is added to the well instead of the En- zyme Solution.
  • Other enzymes may be tested in similar ways using the same reagents, in the case where the enzyme in question yields hydrogen peroxide, or other reagents sensible to the product of the enzyme/substrate reaction.
  • the enzymatic activity is determined (as described in the Enzyme Activity Test above) for the enzyme composition in question at least four times over a relevant period, e.g. every day for at least four days (day 0 to day 3) .
  • t ⁇ is then calculated following standard mathematical methods.
  • the final concentration of immobilised lactate oxidase was around 3400 U/mL.
  • Mylar A polyethyleneterephthalate foil (Whatmann S.A., Louvain La-Neuve, Belgium) (thickness: 10 ⁇ m ⁇ 1 ⁇ m; pore diameter: approx. 0.1 ⁇ m; pore density: 8-10 5 pores/cm 2 ) ;
  • PEG-200- (OH) 2 polyethylene glycol having two hydroxy groups; average molecular weight 200 g/mole; minimum content of tetraethylene glycol: 20%; minimum content of tri-, tetra-, and pentaethylene glycol: 60%
  • the PEG-200 chains on the surface of the membrane layer function as a hydrogel which makes the surface polar and non-reactive so that the ability for, e.g., blood proteins to attach to the surface is reduced or eliminated.
  • a cellulose acetate membrane of the type known in the art, e.g. as described in US 3,979,274 was prepared.
  • Example 2 2.0 ⁇ L of the solution comprising the immobilised lactate oxidase (Example 1) was dispensed to the cellulose acetate membrane layer.
  • the surface modified PETP membrane layer was placed over the cellulose acetate/enzyme layer, and the membrane "sandwich" was al- lowed to dry.
  • compositions were determined in the Stability Test described herein.
  • Enzyme solution C The initial specific enzymatic activity of Enzyme solutions A and B were compared to the initial specific enzymatic activity of the reference (Enzyme solution C) .
  • Oxalate is a competitive inhibitor for lactate oxidase, Oxalate presumably binds to the active site of the enzyme, and it is therefore believed that oxalate will stabilise the enzymatic activity of lactate oxidase in that the enzyme is "locked" in the active conformation when oxalate is present.
  • a solution of 0.04 U/mL lactate oxidase in S4932 rinse solution (Radiometer Medical A/S, Copenhagen, Denmark) was prepared.
  • Disodium oxalate corresponding to a total concentration of 1, 2, 4, 8, and 16 mM of oxalate was added.
  • the enzymatic activity of the solutions was determined five times over a period of 13 days. The enzymatic stability of these solutions was compared with the enzymatic stability of a solution without oxalate.
  • Table 2 shows the results from the spectrophotometrical measurements (OD: Optical Density) and the calculated t ⁇ values.
  • OD Optical Density

Abstract

The present invention relates to an enzyme sensor for measuring the concentration or activity of an analyte of a test fluid. The sensor has at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate. The immobilised enzyme is obtained by formation of one or more covalent link(s), optionally by using a cross-linking agent, between the enzyme and at least one type of macromolecule in the presence of a competitive inhibitor for said enzyme. The present invention also relates to a membrane for an enzyme sensor. Furthermore, the invention relates to a method for stabilising the enzymatic activity of an enzyme sensor.

Description

ENZYME SENSOR
FIELD OF THE INVENTION
The present invention relates to an enzyme sensor for measuring the concentration or activity of an analyte in a test fluid and to a membrane for an enzyme sensor, which have been improved with respect to initial specific enzymatic activity. The present invention also relates to a method for improving the enzymatic stability (the lifetime) of enzyme sensors in general .
BACKGROUND OF THE INVENTION
Enzyme sensors are sensors where a chemical species to be measured (an analyte) undergoes an enzyme catalysed reaction in the sensor before detection. The reaction between the analyte and the enzyme (for which the analyte should be a substrate) yields a secondary species which concentration (under ideal conditions) is proportional with or identical to the concentration of the analyte. The concentration of the secondary species is then detected by a transducer, e.g., by means of an electrode .
The enzyme of an enzyme sensor is typically included in a membrane suited for contacting the test fluid. The enzyme may be included as part of a membrane of a sensor or may be located behind such a membrane. Another alternative is to incorporate the enzyme into the sensor proper, e.g. as part of a carbon paste layer of an electrode. Hence, the analyte is contacted with the enzyme after diffusion into the outer part of the sensor (e.g. the membrane or the carbon paste layer), the en- zyme/analyte reaction takes place, and the secondary species then diffuses to the detector part of the sensor, e.g. an electrode.
In a traditional enzyme sensor comprising a membrane, the membrane must, on the one hand, have a suitable porosity so that the analyte diffuses from the test fluid to the enzyme in a controlled manner, and, on the other hand, be impermeable or substantially impermeable to the enzyme in question in order to avoid leaching of the enzyme into the test fluid.
One way to overcome this problem is to immobilise the enzyme in question to a macromolecule so that the physical size and the general low solubility of the en- zyme/macromolecule prohibit leaching through the porous membrane. A possible alternative, which may be more suited for in-situ polymerised membranes, could be to entrap the enzyme in polymers.
An interesting example of an analyte which is present in, e.g., body fluids is lactate. Lactate sensors wherein lactate oxidase is immobilised to bovine serum albumin are known (Hu et al . , 1993, Analytica Chimica Acta, 281, pp 503-511; Tsuchida et al . , 1985, Biotech- nology and Bioengineering, 27, pp 837-841; Pfeiffer et al., 1992, Biosensors & Bioelectronics, 7, pp 661-671; Baker et al . , 1995, Anal. Chem., 67, pp 1536-1540; and Liu et al., 1995, Electrochemica Acta, 40, pp 1845- 1849) . The reported lifetime of lactate sensors is typically around 14 days (see for example Winckers et al., 1996, Clinical Chemistry, 42, No. S6, p S278, poster No . 761) .
Typically, when an enzyme, e.g. lactate oxidase, is im- mobilised, the initial specific enzymatic activity of the immobilised enzyme is reduced compared to a corresponding amount of non-immobilised enzyme. This may be due to the fact that the enzyme, or at least a part (a domain) thereof, does not retain its active conforma- tion during or after the immobilisation reaction, or that the immobilisation reaction involves functional groups of the enzyme which are situated in or very close to the active site of the enzyme. Thus, a considerable amount of enzyme may be inactivated in the immo- bilisation reaction. The presence of large amounts of inactivated, partially inactivated or denatured enzyme in a sensor is highly undesirable as this may lead to longer response times.
It has been reported that immobilisation of trypsin to a solid phase material in the presence of a competitive inhibitor results in almost full retention of the initial specific enzymatic activity (Kuga et al . , 1976, Mem. Fac. Sci. Kyushu Univ. Ser. C, 10, pp 77-90; CA: 85:42969h) . It has also been described to use a polymeric competitive inhibitor when immobilising trypsin to water-insoluble carriers (Brown et al . , 1981, Makro- mol . Chem., 182, pp 1605-1616). Neither of these publications addresses the use of immobilised trypsin in an enzyme sensor, and, to applicant's best knowledge, no other publications address the use of immobilised trypsin in an enzyme sensor. Thus, the special conditions and requirements applying for immobilised enzymes for enzyme sensors have not been addressed or rendered ob- vious .
The aim of the present invention is to provide enzyme sensors which have an improved initial specific enzymatic activity. Another aim of the present invention is to provide a method for stabilising the enzymatic ac- tivity of enzyme sensors so that the lifetime of enzyme sensors can be prolonged.
SUMMARY OF THE INVENTION
The applicant has now found that enzymes immobilised in the presence of a competitive inhibitor are especially suited for enzyme sensors where a high (initial) ratio between active and inactive enzyme is desirable/re- quired.
Thus, the present invention provides an enzyme sensor for measuring the concentration or activity of an analyte of a test fluid, the sensor having at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the immobilised enzyme being obtained by formation of one or more covalent link(s), optionally by using a cross-linking agent, between the enzyme and at least one type of macromolecule in the presence of a competitive inhibitor for said enzyme .
It is considered non-obvious to utilise immobilised enzymes immobilised in the presence of a competitive in- hibitor in an enzyme sensor. The skilled person would tend to conclude that the competitive inhibitor might have a negative influence on the subsequent measuring properties of the sensor.
The enzyme layer may be applied to the sensor in vari¬ ous ways. Thus, the enzyme layer may be included as part of a membrane of a sensor or may be located behind such a membrane. Alternatively, the enzyme layer may be an integral part of the sensor, e.g. included in a car- bon paste layer of an electrode. In a preferred embodi- ment the enzyme layer is included in a membrane to be mounted to the sensor.
The present invention also provides a membrane for an enzyme sensor for measuring the concentration or activity of an analyte in a test fluid, said membrane having an enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the immobilised enzyme being obtained by formation of one or more cova- lent link(s), optionally by using a cross-linking agent, between the enzyme and at least one type of mac- romolecule in the presence of a competitive inhibitor for said enzyme.
It is believed that enzyme sensors and membranes prepared as defined above result in enzyme sensors and membranes having hitherto unsurpassed high initial specific enzymatic activities compared to conventionally prepared sensors and membranes.
The present invention further provides an enzyme sensor for measuring the concentration or activity of an analyte of a test fluid, the sensor having at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the initial specific enzymatic activity of the immobilised enzyme being at least 50% of the initial specific enzymatic activity of a corresponding amount of non-immobilised enzyme, determined in the same test.
The enzyme may be applied to the sensor as described above .
Further, the present invention provides a membrane for an enzyme sensor for measuring the concentration or ac- tivity of an analyte of a test fluid, said membrane having at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the initial specific enzymatic activity of the immobilised enzyme being at least 50% of the initial specific enzymatic activity of a corresponding amount of non- immobilised enzyme.
In addition, it has been found, in contrast to what should be believed, that the presence of a competitive inhibitor in the enzyme sensor is advantageous not only during the immobilisation reaction, but also afterwards . The applicant has found that it may be especially advantageous to expose the immobilised enzyme included in a sensor to a competitive inhibitor in order to increase the stability of the enzymatic activity and thereby increase the lifetime of a sensor.
Thus, the present invention also provides a method for improving the stability of the enzymatic activity of an immobilised enzyme included in an enzyme sensor, comprising intermittently or continuously exposing the immobilised enzyme to a solution comprising a competitive inhibitor for said enzyme.
The improved stability is obtained both for an enzyme sensor with an immobilised enzyme obtained by formation of covalent link(s) between the enzyme and a macromole- cule in the presence of a competitive inhibitor for the enzyme and for an enzyme sensor with an immobilised enzyme obtained as above, but in the absence of a competitive inhibitor, as well as for any other enzyme sensor with an immobilised enzyme. As mentioned above, the present invention provides novel and highly valuable enzyme sensors and membranes for enzyme sensors. Enzyme sensors have become increasingly important for analytical purposes in that it is desirable, as a matter of routine, to analyse a large number of test fluids with respect to the concentration (or activity) by using fully automatic apparatuses. An example of a fully automatic analysis apparatus for handling biological samples, and for which the novel enzyme sensors are especially suited, is the ABL™ System 625 Blood Gas System (Radiometer Medical A/S, Copenhagen, Denmark) . Such a system is, from the user's side, expected to allow for long operating times ("up" time) and very short and rare service times ("down" time) . Thus, enzyme sensors used in such apparatuses should have a long lifetime. The present invention provides long-life enzyme layers for enzyme sensors.
The analyte to be measured by the enzyme sensor may be any substance which is a substrate for an enzyme which can be included in the membrane of a sensor. Especially interesting analytes in the present context are glucose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglycerides, phenylalanine, tyrosine, and hypoxanthine . An especially relevant analyte in the present context is lactate. Other analytes that might be interesting to measure are glycated amino acids, coagulation factors and sepsis markers.
The selection of a relevant enzyme for a sensor is naturally directed by the analyte. It should also be considered that one of the reaction product (s) of the enzyme/analyte reaction (the secondary species) must be detectable either directly or after subsequent conver- sion into a detectable substance. A preferred secondary species is hydrogen peroxide which may be detected by conventional electrodes.
This being said, preferred enzymes in the present context are those for which an analyte selected from the group consisting of glucose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglyce- rides, phenylalanine, tyrosine, and hypoxanthine is a substrate .
Particularly interesting enzymes are selected from the group consisting of α-hydroxy oxidase (E . C .1.1.3.15) , lactate oxidase (E . C .1.1.3.2. ) , glucose oxidase
(E . C .1.1.3.4 ) , urease (E .C .3.5.1.5) , creatine amidohy- drolase (E . C .3.5.2.10) , creatine amidinohydrolase
(E . C .3.5.3.3) , sarcosine oxidase (E . C .1.5.3.1 ) , gluta- mate dehydrogenase (E .C .1.4.1.3) , pyruvate kinase (E.C.2.7.1.40) , long chain alcohol oxidase
(E .C.1.1.3.20) , and lactate dehydrogenase
(E . C .1.1.1.27 ) , among which lactate oxidase is especially preferred.
The analyte may in principle be present in any type of test fluid, thus, in the present context the term "test fluid" is intended to mean any liquid comprising an analyte which concentration or activity it is desirable to measure.
Limitations with respect to the nature of the test fluid will often be set by the materials selected for the enzyme sensor and, in particular, the membrane. Preferably, the test fluid is an aqueous test fluid, e.g. a test fluid of natural origin. Especially interesting test fluids in the present context are biological samples from animals or humans, especially from humans . Such biological samples may ei- ther be used directly or they may be diluted or treated in various ways in order to remove species which would otherwise interfere with the enzyme, the detector, or the analyte. Examples of biological samples are whole blood, e.g. diluted or undiluted whole blood, blood plasma, blood serum, cerebrospinal fluid, synovial fluid, urine, saliva, and milk. Other interesting test fluids are e.g. dialysis fluids.
The present invention takes advantage of competitive inhibitors in immobilisation reactions and subsequently as stabilising agent. Without being bound to any specific theory, it is believed that the presence of a competitive inhibitor, when covalent links between an enzyme and (a) macromolecule (s) are formed, eliminates or reduces the risk of chemical functionalities in the active site of the enzyme (the site to which a substrate for the enzyme is bound when the enzymatic action is expressed) taking part in the covalent link formation reaction. Thus, it is believed that in the cases where no competitive inhibitor is present, chemical functionalities in the active site, e.g. amino and guanidino groups of lysines and arginines, respectively, may be involved in the covalent bond formation reaction whereby the enzyme activity is reduced or eliminated.
A competitive inhibitor for a specific enzyme is characterised in that it binds in, or in the close proximity of, the active site of the enzyme so that a sub- strate for the enzyme is obstructed from immediately occupying the active site. However, depending on the affinity (for the enzyme in question) and concentration of the competitive inhibitor in relation to the affinity (for the enzyme in question) and concentration of the substrate, there will be a competition (cf. "competitive") between the inhibitor and the substrate for occupation of the active site.
Suitable competitive inhibitors may be any of the com- petitive inhibitors for the enzyme in question known in the art. Also, "partial" competitive inhibitors are to be construed as competitive inhibitors in the present context. However, it is believed that competitive inhibitors especially relevant in the present context are those which, on the one hand, binds efficiently to the enzyme in question during the immobilisation reaction and, on the other hand, can be replaced by the substrate (the analyte) for the enzyme in question when the immobilised enzyme is included in the enzyme sen- sor. It is envisaged that especially suitable competitive inhibitors are those which have an affinity (1/KX) for the enzyme in question which is about 0.0001 to 10 times, such as 0.001 to 5 times, the affinity of the substrate for the same enzyme.
For one of the most interesting enzymes in the present context, i.e. lactate oxidase, preferred competitive inhibitors are selected from the group consisting of oxalacetate, oxalate, α-hydroxy-sulphonate, bisulphite, and phenylacetate . Oxalate has proved to be especially preferred.
Analogous to the presence of competitive inhibitors it should also be understood that any coenzymes necessary for the enzyme to exhibit enzymatic activity is present during the immobilisation reaction so that (i) the immobilisation reaction is performed when the enzyme is present in an active conformation and (ii) the site to which the coenzyme is attached is not blocked by cova- lent links to the macromolecule (s) .
In the present context the term "macromolecule" is to be understood as a high molecular weight molecule, which may be the enzyme proper. The macromolecule should have a chemical functionality which allows for the formation of covalent bonds between the macromolecule and the enzyme in question. It should be understood that the macromolecule may be of natural origin as well as synthetic origin (e.g. a synthetic organic polymer) .
Examples of macromolecules of natural origin are proteins, e.g. albumins and albumin derivatives, such as serum albumin (e.g. bovine serum albumin and bovine se- rum albumin-cysteinyl) , conalbumin (ovotransferrin) , ovalbumin (egg white albumin) , lactalbumin, grain albumin, and soybean albumin.
Examples of macromolecules of synthetic origin are polymeric compounds such as polyolefins and derivatives thereof, e.g. polyethylene, polypropylene, polystyrene, and poly (meth) acrylate, polyester, polyethers, polyal- kylene glycols, e.g. polyethylene glycol, polypropylene glycol, and polybutylene glycol, polyamides, and syn- thetic polypeptides, dextrans, and proteins.
Of the above-mentioned relevant examples, macromolecules selected from the group consisting of albumins and albumin derivatives, such as bovine serum albumin, bovine serum albumin-cysteinyl, conalbumin (ovotrans- ferrin) , and ovalbumin (egg white albumin) , are especially preferred.
The weight average molecular weight of macromolecules particularly relevant in connection with immobilising of enzymes is from 10,000, such as from 10,000 to 1,000,000, preferably 10,000 to 200,000, in particular 20,000 to 100,000.
The immobilisation reaction (cross-linking reaction) may be performed either by direct reaction between the enzyme and the macromolecule or by using a cross- linking agent. Usually a cross-linking agent is required. Cross-linking agents are known to the person skilled in the art, however, especially preferred cross-linking agents for the enzymes described herein are selected from the group consisting of glutaralde- hyde, divinyl sulphone, cyanuric chloride, diisocy- anates, polyisocyanates, diisothiocyanates, and poly- isothiocyanates, among which glutaraldehyde is preferred.
The degree of cross-linking should be so that, on the one hand, leaching of the immobilised enzyme is avoided and, on the other hand, the mobility of the various domains of the enzyme is maintained (otherwise the enzymatic activity will be hampered) . It is believed that a weight average molecular weight of the enzyme/macro- molecule conjugate (the immobilised enzyme) should be at least 100,000, preferably in the range of 100,000 to 5,000,000, in particular 200,000 to 4,000,000, in order for the immobilised enzyme to become unable or substantially unable to diffuse through the outer layer of an enzyme sensor, e.g. a diffusion limiting layer (see further below) , and at the same time be sufficiently soluble or dispersible in an aqueous medium, e.g. a buffer, so that handling is possible prior to inclusion in a membrane.
The immobilised enzymes are preferably prepared as follows: (a) a solution comprising the enzyme, at least one type of macromolecules, and a competitive inhibitor for said enzyme is prepared; and (b) a cross-lmkmg agent is added to the solution. Furthermore, (c) a quenching reagent may be added after the desired reaction time in order to inactivate any remaining cross- linking agent and effectively terminate the reaction. Quenching reagents are reagents which react with the cross-lmkmg agent or any intermediate derived from the cross-lmkmg agent.
It is believed that thorough mixing of the solution comprising the enzyme, the macromolecule, and the competitive inhibitor should be performed m order to es- tablish an equilibrium between dissolved competitive inhibitor and enzyme-bound competitive inhibitor.
The cross-lmkmg reaction should preferably take place at a temperature the range of 0-40°C, more prefera- bly m the range of 10-30°C, so that the enzyme is not denatured during the cross-lmkmg reaction. Preferably the cross-lmkmg reaction is performed at ambient temperature .
With respect to the reaction medium, it is believed that an aqueous medium is preferred over an organic media. The aqueous medium should preferably be a buffer adjusted to the a pH value the range of 5.0-9.0, in particular m the range of 6.0-8.0. Phosphate buffers are especially preferred. In an embodiment of the present invention, immobilised lactate oxidase for the sensor is prepared from 4-7 parts by weight, such as 5-6 parts by weight, of lac- tate oxidase, 8-12 parts by weight, such as 9-11 parts by weight, of bovine serum albumin-cysteinyl, and 1.5- 3.5 parts by weight, such as 2-3 parts by weight, of cross-linking agent using 12-15 parts by weight, such as 13-14 parts by weight, of sodium oxalate (see Exam- pie 1) .
It should be understood that it may be advantageous to add a competitive inhibitor for the enzyme in the case where the immobilised enzyme is to be stored before in- elusion in a sensor or a membrane for a sensor.
The enzyme of an enzyme sensor is typically included in a membrane suited for contacting the test fluid.
The membranes according to the invention are preferably membranes comprising an enzyme layer included as part of a membrane or located behind such a membrane. The membrane may serve several purposes including providing protection from potentially harmful substances in the test fluid, ascertaining retention of the enzyme in the membrane and providing optimal diffusion limiting conditions for the analyte to be measured in order to obtain sufficient linearity for the sensor.
Thus, it is preferred that the membranes comprise a diffusion limiting layer which is adapted to separate the enzyme layer and the test fluid. The diffusion limiting layer is a porous membrane layer which limits the diffusion of the analyte into the enzyme layer so that the capacity of the immobilised enzyme for conversion of the analyte is not exceeded, and so that sufficient 02 for the enzymatic conversion of the analyte is present in the enzyme layer. The principle of diffusion limiting layers is described in Danish Patent No. 170103.
The diffusion limiting layer may consist of a membrane of a type normally used for sensors. These comprise solution/diffusion type membranes (e.g. hydrogels), track etch membranes (having straight pores), composite membranes and tortuous path membranes.
The material for the diffusion limiting layer may include any membrane material for sensors known in the art. Examples are polyolefins and derivatives thereof, e.g. polyethylene, polypropylene, polystyrene, and poly (meth) acrylate, polyester, polyethers, polyalkylene glycols, e.g. polyethylene glycol, polypropylene gly¬ col, and polybutylene glycol, polyamides, silicones and regenerated cellulose. Polyesters such as polyethylene terephthalate may be especially suitable. Other polymers such as e.g. polycarbonates and polyurethanes may be useful as well.
In a preferred embodiment the diffusion limiting layer has through-going pores which are permeable to the analyte and impermeable or substantially impermeable to the immobilised enzyme, and at least a part of the pores should, of course, extend from the surface of the diffusion limiting layer adapted to face the test fluid to the surface of the diffusion limiting layer adapted to face the enzyme layer.
It should be understood that the through-going pores of the diffusion limiting layer have walls, and that the surface of these walls together with the surface adapted to face the test fluid define an accessible surface of the diffusion limiting layer, i.e. the surface accessible to the test fluid. This accessible sur- face of the diffusion limiting layer should preferably be hydrophilic so that, e.g., blood proteins do not become attached to the surface. Thus, the accessible surface of the diffusion limiting layer may, if it is not in itself sufficiently hydrophilic, have derivatisable chemical groups of which at least a part are deriva- tised with a hydrophilic component whereby the accessible surface is rendered more hydrophilic than a corresponding non-derivatised surface.
The derivatisable chemical groups may be present in the natural form of the membrane layer material, or they may arise after treatment of the membrane layer material with a chemical reagent, or after irradiation of the membrane .
The hydrophilic component should be selected so that the surface treated membrane layer is not degraded under the normal cleaning and rinse conditions applicable for enzyme sensors. Thus, it is envisaged that polyal- kylene glycols such as polyethylene glycol (PEG) , hepa- rin, hyaluronic acid, phospholipids, agarose, chitosan, cyclodextrin, alginate, collagen, lignin, pectin as well as polysaccharides and cellulose-based polymers such as dextrin, hydroxyalkylcelluloses, cellulose ace- tates, albumin, gelatine, agar, carageenans, and starch are suited as hydrophilic components. Also, hydrophilic synthetic organic polymers, e.g. polyvinylalcohol/poly- vinylacetates, polyvinylpyrrolidone, hydroxyalkyl- (meth) acrylates such as hydroxymethyl (meth) acrylate and hydroxyethyl (meth) acrylate, (meth) acrylic acid, allyl- alcohol, and acrylpolymers (hydrogels) may be used.
Among these possible hydrophilic components, polyethylene glycol and heparin are especially interesting. Furthermore, polyethylene glycols having an average molecular weight of from about 100 to about 2000, such as from about 200 to about 1000, are believed to be especially relevant as hydrophilic components.
It should be understood that for practical reasons, often the entire surface of the membrane layer and the pores are modified, i.e. also the surface of the membrane layer adapted to face the enzyme layer.
The membrane according to the invention may further comprise an interference eliminating layer which is permeable to the product from the enzyme/analyte reaction and impermeable or substantially impermeable to the analyte and the immobilised enzyme. The interference eliminating layer should preferably also be impermeable to other chemical components which may be present in the test fluid. A very suitable material, which is impermeable to, e.g., HEPES, ascorbic acid, and paracetamol and permeable to, e.g., H202, is cellulose acetate .
Thus, in an embodiment of the present invention, the membrane comprises:
(a) a diffusion limiting layer comprising polyethylene terephthalate, the accessible surface of the diffusion limiting layer having carboxyl groups, at least a part of these carboxyl groups being derivatised by cova- lently linking thereto polyethylene glycol having an average molecular weight in the range of 100-1000;
(b) an enzyme layer comprising immobilised lactate oxi- dase, and
(c) an interference limiting layer comprising cellulose acetate .
The individual membrane layers are cut in congruent pieces and are assembled, e.g., in a membrane ring. The membrane preferably has a thickness in the range of 10- 50 μm, in particular in the range of 10-30 μm. The diffusion limiting porous membrane layer is preferably 5- 20 μm, the enzyme layer is preferably 1-3 μm, and the interference limiting layer is preferably 5-10 μm.
The sensor according to the present invention may be based on one or several applicable detector principles, such as electrochemical or optical principles. Thus, the detector part face of the sensor may, e.g., be a part of an electrode or an optical detector. Prefera¬ bly, the detector part of the sensor is a part of an electrode .
An electrode may comprise an anode of e.g. carbon paste or platinum, gold, iridium, rhodium, palladium and al¬ loys or pastes thereof, and a reference electrode of e.g. silver/silver chloride, silver/silver oxide, or mercury/mercury (I) chloride. The electrode may further comprise any necessary electrolyte solution. Prefera¬ bly, the electrode comprises a platinum anode and silver/silver chloride reference electrode. As it has been described above, the present invention provides enzyme sensors and membranes for enzyme sensors where the initial specific enzymatic activity has been improved. Thus, in an embodiment of the present invention, the initial specific enzymatic activity of the immobilised enzyme included in a membrane for an enzyme sensor is at least 50% of the initial specific enzymatic activity of a corresponding amount of non- immobilised enzyme. Preferably and also realistically, the initial specific enzymatic activity is at least
60%, such as at least 70%, in particular at least 80% or even at least 90%, compared to the initial specific enzymatic activity of a corresponding amount of non- immobilised enzyme.
In Example 4, the initial specific enzymatic activity for immobilised lactate oxidase is 78% (Table 1) . Thus, immobilised lactate oxidase prepared as described in Example 4 will, when incorporated in a membrane for an enzyme sensor, constitute a preferred embodiment of the present invention.
In a further embodiment of the present invention, the initial specific enzymatic activity of the immobilised enzyme is at least 1.5 times the initial specific enzymatic activity of a corresponding amount of enzyme immobilised to the same kind of macromolecule by using, if applicable, the same kind of cross-linking agent in the absence of a competitive inhibitor for said enzyme. In Example 4, it has been shown that immobilised lactate oxidase fulfils this criteria, cf. Table 1.
As it should be clear from the above, the present invention provides enzyme sensors and membranes for en- zyme sensors which may be designed so that they have an hitherto unsurpassed lifetime. Thus, when using a specific amount of (non-immobilised) enzyme in the immobilisation reaction defined herein, the initial specific enzymatic activity is higher than when using conven- tional conditions, and, consequently, the period before the enzymatic activity reaches the level where the sensor becomes unusable is prolonged.
Apart from the novel long-life enzyme sensors, the ap- plicant has found that storage of enzymes in a medium comprising a competitive inhibitor for the enzyme improves the stability of the enzymatic activity (see Example 5) . Thus, as mentioned above, the present invention provides a method for improving the stability of the enzymatic activity of an immobilised enzyme included in an enzyme sensor for measuring the concentration of an analyte in a test fluid, the analyte being a substrate for the enzyme, the method comprising intermittently or continuously exposing the immobilised en- zyme to a solution comprising a competitive inhibitor for said enzyme.
With respect to the definition of the sensor, enzyme, and competitive inhibitor, etc., the definitions and preferred embodiments mentioned above also apply here. Thus, the immobilised enzyme may be included as an integral part of the sensor, or included in a membrane of the enzyme sensor.
It should be understood that the method may be equally applicable in the case where a replacement membrane for an enzyme sensor has to be stored before it is mounted to the sensor. Thus, the present invention also provides a method for improving the stability of the enzy- matic activity of an immobilised enzyme included in a membrane for an enzyme sensor.
In a very interesting embodiment where the method is performed for an enzyme sensor either used separately or included in a fully automatic apparatus, the enzyme layer comprising the immobilised enzyme is exposed to a solution comprising a competitive inhibitor for said enzyme between each or substantially each measurement, or between each or substantially each series of measurements, of the analyte. Thus, in order to optimise the rinsing process for a sensor and avoid that the exposure of the enzyme layer to the competitive inhibitor becomes a separate operation step, the competitive in- hibitor may be included in the rinse fluid for said sensor .
The concentration of the competitive inhibitor in the rinse fluid should preferably be so that, when the en- zyme in question is permanently stored in the rinse fluid comprising the competitive inhibitor at that specific concentration, the increase in t^ for the enzymatic activity would be at least 50%, such as at least 100%, in particular at least 200%.
Relevant competitive inhibitors which, on the one hand, have the ability to efficiently stabilise an enzyme composition, especially an immobilised enzyme composition, and, on the other hand, allow for the enzymatic reaction to take place in the (simultaneous) presence of a substrate for the enzyme, are those which have a binding affinity for the active site of the enzyme which is equal to, or slightly lower than, the binding affinity of the relevant substrate. In an especially interesting embodiment, the method is performed for lactate oxidase included in an enzyme sensor for measuring lactate in a biological sample.
This highly valuable principle for stabilising the enzyme activity may be used for enzyme sensors in general, thus, the present invention also relates to the use as a stabilising agent for an immobilised enzyme included in an enzyme sensor of a solution comprising a competitive inhibitor for said enzyme. Such a solution may be a rinse or cleaning fluid for the sensor. It should, however, be noted that a solution comprising a competitive inhibitor may also be used for the stabilisation of non-immobilised enzymes or enzymes which have been immobilised in other ways than described herein.
The enzyme sensors and the membranes described herein are especially suited for use in fully automatic apparatuses for measuring the concentration or activity of one or more analytes in a test fluid. In such commercially available fully automatic apparatuses it is possible, even with only minor reconstruction efforts or replacement of the rinse fluid (s) for the enzyme sensor (s), to utilise the method according to the inven- tion.
Thus, the present invention also provides an apparatus for measuring the concentration or activity of one or more analytes of a test fluid, the apparatus comprising an enzyme sensor having a layer of an immobilised enzyme for which at least one of the analytes is a substrate, wherein the apparatus further comprises one or more containers with solution (s) needed for the operation of the apparatus, at least one solution comprising a competitive inhibitor for the enzyme, and means for intermittently exposing the sensor to the solution comprising the competitive inhibitor.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 illustrates an enzyme sensor 1 comprising an electrode and a membrane,
Fig. 2 illustrates in detail the membrane part of the membrane of Fig. 1, and
Fig. 3 illustrates in schematic form an embodiment of an apparatus according to the invention.
DETAILED DESCRIPTION OF THE INVENTION
Fig. 1 shows an enzyme sensor 1 for measuring lactate. Enzyme catalysed reaction between lactate and oxygen yields hydrogen peroxide (H202) and pyruvate. Hydrogen peroxide is then detected by an amperometric electrode. The sensor 1 is suited for mounting in an apparatus for measuring the concentration of analytes in a biological sample, e.g. an ABL™ 625 Blood Gas System (Radiometer Medical A/S, Copenhagen, Denmark) .
Basically, the sensor 1 comprises an electrode 2 onto which a membrane ring 3 is attached. The electrode 2 comprises a platinum anode 4 connected with a platinum wire 5, which, through a micro plug 6, is connected with an silver anode contact body 7. The platinum anode 4 and the lower part of the platinum wire 5 is sealed into a glass body 8. Between the glass body 8 and the micro plug 6, the platinum wire 5 is protected with a heat shrink tubing. A tubular silver reference elec- trode 10 encircles the upper part of the glass body 8 and extends in the length of the electrode 2 to the anode contact body 7, which is fastened inside the reference electrode by means of a fixing body 11 and epoxy 12. The lower part of the glass body 8 is surrounded by an electrode base 13 whereto the membrane ring 3 is attached.
The upper part of the reference electrode 10 is surrounded by a plug part 14 for mounting the electrode 2 in the corresponding plug of an analysis apparatus (not shown) and for fixing a mantle 15. Gaskets 16 and 17 are placed between the electrode 2 and the mantle 15 in order to ensure that any electrolyte located at the measuring surface of the electrode 2 does not evapo- rate. The membrane ring 3, which is mounted at one end of the mantle 15, comprises a ring 20. A membrane 21 is stretched over the lower opening of the ring 20. This membrane 21 is shown in detail in Figure 2.
Fig. 2 shows a membrane 21 comprising three layers: an interference limiting membrane layer 22 facing the platinum anode 4 of the electrode 2, an enzyme layer 23, and a diffusion limiting porous membrane layer 24 facing the test fluid. The interference limiting mem- brane layer 22 may be a 6 ± 2 μm porous membrane of cellulose acetate (CA) . The enzyme layer is typically an approx. 1-2 μm layer of cross-linked lactate oxidase (7 units/membrane). The diffusion limiting porous membrane layer 24 may be an approx. 10 μm layer of poly- ethylenetherephthalate (PETP) (pore diameter approx. 0.1 μm; pore density: 8-105 pores/cm2).
Fig. 3 shows in schematic form an embodiment of an apparatus 30 according to the invention. The apparatus 30 comprises several sensors 1, 31-36 for measuring the concentration or activity of different analytes in a test fluid. The sensors include a reference electrode 31, sensors for measuring e.g. pH, p02, p02, etc. 32-36 and an enzyme sensor 1 for measuring lactate similar to the sensor described above in connection with Figs. 1 and 2. The sensors 1, 31-36 are located in a measuring section shown by the dotted line 38.
The apparatus 30 has an inlet 40 for introduction of a test fluid into the apparatus 30 and several containers 50-54 with solutions needed for the operation of the apparatus 30. Thus, the container 50 comprises a salt- bridge solution for the reference electrode 31, the containers 51 and 53 comprise different calibration so- lutions for the sensors 1, 32-36, the container 52 comprises a cleaning solution for the sensors 1, 32-36 and finally the container 54 comprises a rinse solution for the sensors 32-36. The rinse solution of the container 54 comprises oxalate which as mentioned previously is a competitive inhibitor for the lactate oxidase enzyme in the lactate enzyme sensor 1.
The apparatus 30 further includes a waste container 55 and air inlets 56, 57. A fluid conduit system (shown in dark lines) connects the inlet 40, the containers 50-55 and the air inlets 56, 57 with the sensors 1, 31-36. Test fluid from the inlet, solutions from the different containers 50-54 and optionally air from the air inlets 56, 57 may be transferred in the fluid conduit system by means of pumps 61, 62 and a main valve 63 controlled by not shown software means of the apparatus 30.
When a test fluid has been introduced into the inlet, the pumps 61, 62 and the main valve 63 are activated to transfer the test fluid to the measuring section 28 and the test fluid is analysed. Then the test fluid is transferred to the waste container 55. A rinse operation is now performed comprising activating the pumps 61, 62 and main valve 63 to transfer rinse fluid from the container 54 through the fluid conduit system to the sensors 1, 31-36 in the measuring section 28 and thence to the waste container 55. During this rinse operation the lactate enzyme sensor 1 is exposed to the oxalate contained in the rinse fluid. Thus, the lactate enzyme sensor 1 included in the apparatus 30 will be frequently exposed to the competitive inhibitor oxalate as this takes place in between each measurement performed on the apparatus 30.
TESTS SPECIFICATIONS
Enzyme Activity Test
Colorimetric lactate oxidase assay
Lactate oxidase (LOD) catalyses the reaction:
L-lactate + ^02 + H20 → pyruvate + H202
The formation of H202 is determined in a peroxidase
(POD) assay system where a quinonimine dye is formed. The amount of formed quinonimine dye is determined spectrophotometically at 490 nm.
Peroxidase catalyses the reaction:
H202 + 4-hydroxybenzenesulfonic acid + 4-aminoantipyrine —> quinonimine (λmax: 505 nm) Procedure :
Reagent A:
2 mL 3,3-dimethylglutaric acid/NaOH (50 mM) buffer pH 6.5
1 mL peroxidase (50 U/mL; 3.25 mg in 10 mL H20)
1 mL 4-aminoantipyrine, 15 mM in H20
1 L DL-lactate 0.5 M, adjusted to pH 6.5 with NaOH 3 mL H20
2 mL 0.2% v/v 4-hydroxybenzenesulfonic acid in H20
Enzyme Solution (enzyme composition to be tested) :
10 mL (immobilised) lactate oxidase (test solution approx. 0.04 U/mL in a 5 mM KH2P04/NaOH buffer pH 7.0)
Reference Enzyme Solution:
10 mL lactate oxidase (Pediococcus) 0.04 U/mL in a 5 mM KH2P04/NaOH buffer pH 7.0
100 μL of Reagent A is added to a well of a microtiter- plate ( Immunoplate, Nunc, Roskilde, Denmark) . The col- our reaction is started by adding 100 μL of the Enzyme Solution. Immediately afterwards, the microtiterplate is placed in the plate-holder of a THERMOmax incubator (Molecular Devices, Menlo Park, CA, USA) pre-set to: 37°C, kinetic mode, lag-time 5 min., reading time 15 min., and automix.
In order to obtain a reference value for the initial specific enzymatic activity, 100 μL of the Reference
Enzyme Solution is added to the well instead of the En- zyme Solution. Other enzymes may be tested in similar ways using the same reagents, in the case where the enzyme in question yields hydrogen peroxide, or other reagents sensible to the product of the enzyme/substrate reaction.
Enzyme Stability Test
The enzymatic activity of lactate oxidase (and also other enzymes) is decreasing exponentially. Therefore, the half-life period (tij) for the enzymatic activity will be independent of the initial concentration, and, thus, t^ is an excellent expression for the stability of an enzyme under various conditions.
The enzymatic activity is determined (as described in the Enzyme Activity Test above) for the enzyme composition in question at least four times over a relevant period, e.g. every day for at least four days (day 0 to day 3) . t^ is then calculated following standard mathematical methods.
EXAMPLES
Example 1
Preparation of immobilised lactate oxidase
2720 Units of lactate oxidase and 40.0 mg bovine serum albumin-cysteinyl were dissolved in 400 μL 10 mM phosphate buffer (pH 7.0) and 1.60 mL 250 mM disodium oxalate. The mixture was mixed for 10 min. at 200 vibrations per min. 400 μL 2.5 % (v/v aq. ) glutaraldehyde was added, and the mixture was stirred for 10 min. The mixture was quenched with 100 μL 1M glycine . The immobilised lactate oxidase was ultra-filtered to a volume of 400 μL . Then, 400 μL of a 10 mM imidazole buffer (pH 7.0) containing 40% sucrose was added.
The final concentration of immobilised lactate oxidase was around 3400 U/mL.
Example 2
Preparation of modified PETP membrane layer
Materials :
Mylar A polyethyleneterephthalate foil (Whatmann S.A., Louvain La-Neuve, Belgium) (thickness: 10 μm ± 1 μm; pore diameter: approx. 0.1 μm; pore density: 8-105 pores/cm2) ;
10 g PEG-200- (OH) 2 (polyethylene glycol having two hydroxy groups; average molecular weight 200 g/mole; minimum content of tetraethylene glycol: 20%; minimum content of tri-, tetra-, and pentaethylene glycol: 60%) ;
2 g CMC-MTS ( l-cyclohexyl-3- ( 2-morpholinoethyl ) carbo- diimide metho-p-toluenensulf onate , 95% ) as coupling reagent ;
0 . 2 g Triton CF-54 ; and
4000 mL demineralised water (pH 6.0-6.5) The PETP-material was cut in sheets and each sheet was fastened in a frame. The frame was suspended for 18 hours in a reaction mixture consisting of PEG-200- (OH)2, CMC-MTS, Triton CF-54, and water. The sheets were then washed under stirring for 15 min. with 0.1% Triton X-100 in demineralised water, and subsequently washed twice with demineralised water for 2 x 10 min. Finally, the sheets were dried for at least 16 hours in a hood. All operations were performed at room tempera- ture .
The PEG-200 chains on the surface of the membrane layer function as a hydrogel which makes the surface polar and non-reactive so that the ability for, e.g., blood proteins to attach to the surface is reduced or eliminated.
Example 3
Preparation of a membrane
A cellulose acetate membrane of the type known in the art, e.g. as described in US 3,979,274 was prepared.
2.0 μL of the solution comprising the immobilised lactate oxidase (Example 1) was dispensed to the cellulose acetate membrane layer. The surface modified PETP membrane layer was placed over the cellulose acetate/enzyme layer, and the membrane "sandwich" was al- lowed to dry.
The membrane could then be incorporated in a membrane ring for an enzyme sensor. Example 4
Effect of using oxalate in cross-linking reactions
Three enzyme solutions, A, B, and C were prepared as follows :
Basis solution
20 mg (680 units) lactate oxidase and 10 mg bovine serum albumin-cysteinyl were dissolved in 100 μL 10 mM phosphate buffer (pH 7.0) under stirring for 5 min. 25 μL of this solution was used for each of the solutions A-C.
Enzyme solution A
100 μL 250 mM disodium oxalate was added to the basis solution followed by stirring for 5 min. 25 μL 2.5% (v/v aq.) glutaraldehyde was added and stirring was continued for 10 min. and then 6.25 μL 1 M glycine was added .
Enzyme solution B (without competitive inhibitor)
100 μL distilled water was added to the basis solution followed by stirring for 5 min. 25 μL 2.5% (v/v aq.) glutaraldehyde was added and stirring was continued for 10 min. and then 6.25 μL 1 M glycine was added.
Enzyme solution C (without cross-linking agent)
100 μL 250 mM disodium oxalate was added to the basis solution followed by stirring for 5 min. 25 μL dis- tilled water was added and stirring was continued for 10 min. and then 6.25 μL 1 M glycine was added.
Each of the solutions were diluted to 0.04 U/mL with a 10 mM imidazole buffer (pH 7.0).
The stability of the compositions were determined in the Stability Test described herein.
The initial specific enzymatic activity of Enzyme solutions A and B were compared to the initial specific enzymatic activity of the reference (Enzyme solution C) .
Table 1
Figure imgf000034_0001
The results in Table 1 show that the initial specific enzymatic activity after cross-linking of lactate oxidase in the presence of oxalate is 78% compared with the initial specific enzymatic activity of the reference non-immobilised enzyme. Cross-linking in the absence of oxalate results in an initial specific enzymatic activity of only 37%.
Example 5
Oxalate as stabilising agent for lactate oxidase
Oxalate is a competitive inhibitor for lactate oxidase, Oxalate presumably binds to the active site of the enzyme, and it is therefore believed that oxalate will stabilise the enzymatic activity of lactate oxidase in that the enzyme is "locked" in the active conformation when oxalate is present.
A solution of 0.04 U/mL lactate oxidase in S4932 rinse solution (Radiometer Medical A/S, Copenhagen, Denmark) was prepared. Disodium oxalate corresponding to a total concentration of 1, 2, 4, 8, and 16 mM of oxalate was added. The enzymatic activity of the solutions was determined five times over a period of 13 days. The enzymatic stability of these solutions was compared with the enzymatic stability of a solution without oxalate.
Table 2
Table 2 shows the results from the spectrophotometrical measurements (OD: Optical Density) and the calculated t^ values. The t^ values for the solutions clearly show that the presence of oxalate has a remarkably positive effect on the stability. For the highest concentration, 16 mM, the stability (quoted as t^) was tripled. Thus, the slightly lower initial specific enzymatic activity is fully compensated for after 8-9 days.

Claims

C L A I M S
1. An enzyme sensor for measuring the concentration or activity of an analyte of a test fluid, the sensor having at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the immobilised enzyme being obtained by formation of one or more covalent link(s), optionally by using a cross-linking agent, between the enzyme and at least one type of macromolecule in the presence of a competitive inhibitor for said enzyme.
2. An enzyme sensor according to claim 1, wherein the enzyme layer is included in a membrane of the enzyme sensor.
3. An enzyme sensor according to claim 1 or 2, wherein the enzyme is selected from enzymes for which a substance selected from the group consisting of glucose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglycerides, phenylalanine, tyrosine, and hypox- anthine is a substrate.
4. An enzyme sensor according to any of the claims 1-3, wherein the enzyme is lactate oxidase.
5. An enzyme sensor according to any of the claims
1-4, wherein the enzyme is immobilised to a macromolecule selected from the group consisting of albumins and albumin derivatives, such as bovine serum albumin, bovine serum albumin-cysteinyl, con- albumin (ovotransferrin) , and ovalbumin (egg white albumin) .
6. An enzyme sensor according to any of the claims 1-5, wherein the initial specific enzymatic activity of the immobilised enzyme is at least 50% of the initial specific enzymatic activity of a corresponding amount of non-immobilised enzyme.
7. An enzyme sensor according to any of the claims
1-6, wherein the enzyme is lactate oxidase and the competitive inhibitor is selected from the group consisting of oxalacetate, oxalate, α-hydroxy- sulphonate, bisulphite, and phenylacetate .
8. An enzyme sensor according to claim 7, wherein the competitive inhibitor is oxalate.
9. An enzyme sensor according to any of the claims 1-8, wherein the initial specific enzymatic activity of the immobilised enzyme is at least 1.5 times the initial specific enzymatic activity of a corresponding amount of enzyme immobilised to the same kind of macromolecule by using, if applica- ble, the same kind of cross-linking agent in the absence of a competitive inhibitor for said enzyme .
10. An enzyme sensor for measuring the concentration or activity of an analyte of a test fluid, the sensor having at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the initial specific enzymatic activity of the immobilised enzyme being at least 50% of the initial specific enzymatic activity of a corresponding amount of non-immobilised enzyme.
11. An enzyme sensor according to claim 10, wherein the enzyme layer is included in a membrane of the enzyme sensor.
12. An enzyme sensor according to claim 10 or 11, wherein the enzyme is selected from enzymes for which a substance selected from the group consisting of glucose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglycerides, phenylalanine, tyrosine, and hypox- anthine is a substrate.
13. An enzyme sensor according to any of the claims 10-12, wherein the enzyme is lactate oxidase.
14. An enzyme sensor according to any of the claims
10-13, wherein the enzyme is immobilised to a macromolecule selected from the group consisting of albumins and albumin derivatives, such as bovine serum albumin, bovine serum albumin-cysteinyl, conalbumin (ovotransferrin) , and ovalbumin (egg white albumin) .
15. An enzyme sensor according to any of the claims 10-14, wherein the initial specific enzymatic ac- tivity of the immobilised enzyme is at least 60% of the initial specific enzymatic activity of a corresponding amount of non-immobilised enzyme.
16. A membrane for an enzyme sensor for measuring the concentration or activity of an analyte in a test fluid, said membrane having at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the initial specific enzymatic activity of the immobilised enzyme being at least 50% of the initial specific enzymatic activity of a corresponding amount of non- immobilised enzyme.
17. A membrane according to claim 16, wherein the en- zyme is selected from enzymes for which a substance selected from the group consisting of glucose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglycerides, phenylalanine, tyrosine, and hypoxanthine is a substrate .
18. A membrane according to claim 16 or 17, wherein the enzyme is lactate oxidase.
19. A membrane according to any of the claims 16-18, wherein the enzyme is immobilised to a macromolecule selected from the group consisting of albumins and albumin derivatives, such as bovine serum albumin, bovine serum albumin-cysteinyl, conalbumin (ovotransferrin) , and ovalbumin (egg white albumin) .
20. A membrane according to any of the claims 16-19, wherein the initial specific enzymatic activity of the immobilised enzyme is at least 60% of the initial specific enzymatic activity of a corresponding amount of non-immobilised enzyme.
21. A membrane for an enzyme sensor for measuring the concentration or activity of an analyte in a test fluid, said membrane having at least one enzyme layer comprising an immobilised enzyme for which the analyte is a substrate, the immobilised enzyme being obtained by formation of one or more covalent link(s), optionally by using a cross-linking agent, between the enzyme and at least one type of macromolecule in the presence of a competitive in- hibitor for said enzyme.
22. A membrane according to claim 21, wherein the enzyme is selected from enzymes for which a substance selected from the group consisting of glu- cose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglycerides, phenylalanine, tyrosine, and hypoxanthine is a substrate .
23. A membrane according to claim 21 or 22, wherein the enzyme is lactate oxidase.
24. A membrane according to any of the claims 21-23, wherein the enzyme is immobilised to a macromolecule selected from the group consisting of albumins and albumin derivatives, such as bovine serum albumin, bovine serum albumin-cysteinyl, conalbumin (ovotransferrin) , and ovalbumin (egg white al- bumin) .
25. A membrane according to any of the claims 21-24, wherein the initial specific enzymatic activity of the immobilised enzyme is at least 50% of the ini- tial specific enzymatic activity of a corresponding amount of non-immobilised enzyme.
26. A membrane according to any of the claims 21-25, wherein the enzyme is lactate oxidase and the competitive inhibitor is selected from the group consisting of oxalacetate, oxalate, α-hydroxy- sulphonate, bisulphite, and phenylacetate .
27. A membrane according to claim 26, wherein the competitive inhibitor is oxalate.
28. A membrane according to any of the claims 21-27, wherein the initial specific enzymatic activity of the immobilised enzyme is at least 1.5 times the initial specific enzymatic activity of a corresponding amount of enzyme immobilised to the same kind of macromolecule by using, if applicable, the same kind of cross-linking agent in the absence of a competitive inhibitor for said enzyme.
29. A method for improving the stability of the enzymatic activity of an immobilised enzyme included in an enzyme sensor for measuring the concentra- tion of an analyte in a test fluid, the analyte being a substrate for said enzyme, the method comprising intermittently or continuously exposing the immobilised enzyme to a solution comprising a competitive inhibitor for said enzyme.
30. A method according to claim 29, wherein the immo¬ bilised enzyme is included in a membrane of the enzyme sensor.
31. A method according to claim 29 or 30, wherein the enzyme is exposed to a solution comprising a competitive inhibitor for said enzyme between each or substantially each measurement, or between each or substantially each series of measurements, of the analyte .
32. A method according to claim 31, wherein the solution comprising the competitive inhibitor is a rinse fluid for said sensor.
33. A method according to any of the claims 29-32, wherein the enzyme is selected from enzymes for which a substance selected from the group consist- ing of glucose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglycerides, phenylalanine, tyrosine, and hypoxanthine is a substrate.
34. A method according to claim 33, wherein the enzyme is lactate oxidase.
35. A method according to claim 34, wherein the com- petitive inhibitor is selected from the group consisting of oxalacetate, oxalate, α-hydroxy- sulphonate, bisulphite, and phenylacetate .
36. A method according to claim 35, wherein the com- petitive inhibitor is oxalate.
37. The use as a stabilising agent for an immobilised enzyme included in an enzyme sensor of a solution comprising a competitive inhibitor for said enzyme wherein the enzyme sensor is adapted for measuring the concentration or activity of an analyte in a test fluid, the analyte being a substrate for the enzyme .
38. The use according to claim 37, wherein the immobilised enzyme is included in a membrane of the enzyme sensor.
39. The use according to claim 37 or 38, wherein the enzyme is selected from enzymes for which a substance selected from the group consisting of glucose, cholesterol, lactate, creatine, creatinine, urea, uric acid, pyruvate, alcohols, bilirubin, ascorbate, phosphate, proteins, triglycerides, phenylalanine, tyrosine, and hypoxanthine is a substrate .
40. The use according to claim 39, wherein the enzyme is lactate oxidase and the analyte is lactate.
41. The use according to claim 40, wherein the competitive inhibitor is selected from the group consisting of oxalacetate, oxalate, α-hydroxy- sulphonate, bisulphite, and phenylacetate .
42. The use according to claim 41, wherein the competitive inhibitor is oxalate.
43. The use according to any of the claims 37-42, wherein the solution comprising the competitive inhibitor is a rinse fluid for said sensor.
44. An apparatus for measuring the concentration or activity of one or more analyte (s) of a test fluid, the apparatus comprising an enzyme sensor having at least one layer of an immobilised enzyme for which at least one of the analytes is a substrate, wherein the apparatus further comprises one or more containers with solution (s) needed for the operation of the apparatus, at least one solution comprising a competitive inhibitor for the enzyme, and means for intermittently exposing the sensor to the solution comprising the competitive inhibitor .
45. An apparatus according to claim 44, wherein the immobilised enzyme is included in a membrane of the enzyme sensor.
46. An apparatus according to claim 44 or 45, wherein the solution comprising the competitive inhibitor is a rinse fluid for said sensor.
47. An apparatus according to any of the claims 44-46, wherein the analyte is lactate, the enzyme is lactate oxidase and the competitive inhibitor of the solution is oxalate.
PCT/DK1997/000508 1996-11-14 1997-11-07 Enzyme sensor WO1998021356A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP10522060A JP2000507457A (en) 1996-11-14 1997-11-07 Enzyme sensor
US09/308,212 US6051389A (en) 1996-11-14 1997-11-07 Enzyme sensor
DE69735127T DE69735127T2 (en) 1996-11-14 1997-11-07 ENZYME SENSOR
EP97912066A EP0944731B1 (en) 1996-11-14 1997-11-07 Enzyme sensor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK128596 1996-11-14
DK1285/96 1996-11-14

Publications (1)

Publication Number Publication Date
WO1998021356A1 true WO1998021356A1 (en) 1998-05-22

Family

ID=8103128

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1997/000508 WO1998021356A1 (en) 1996-11-14 1997-11-07 Enzyme sensor

Country Status (7)

Country Link
US (1) US6051389A (en)
EP (1) EP0944731B1 (en)
JP (1) JP2000507457A (en)
AT (1) ATE316147T1 (en)
DE (1) DE69735127T2 (en)
DK (1) DK0944731T3 (en)
WO (1) WO1998021356A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006122552A1 (en) 2005-05-17 2006-11-23 Radiometer Medical Aps Method of stabilising or reactivating a creatinine sensor with a solution of a divalent manganese ion
WO2006122554A2 (en) 2005-05-17 2006-11-23 Radiometer Medical Aps Enzyme sensor with a cover membrane layer covered by a hydrophilic polymer
EP2261647A1 (en) * 2001-05-31 2010-12-15 Instrumentation Laboratory Company Cross-linked enzyme matrix and uses thereof
CN104198556A (en) * 2014-08-11 2014-12-10 南京普朗医疗设备有限公司 Preparation method of electrode membrane based on lactate oxidase and product prepared by the method
WO2020204975A1 (en) * 2019-04-05 2020-10-08 Instrumentation Laboratory Company Multi-enzymatic biosensors and stabilization of multi-enzymatic biosensors at room temperature

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8527026B2 (en) 1997-03-04 2013-09-03 Dexcom, Inc. Device and method for determining analyte levels
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US6001067A (en) 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US20020002039A1 (en) 1998-06-12 2002-01-03 Safi Qureshey Network-enabled audio device
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6582583B1 (en) * 1998-11-30 2003-06-24 The United States Of America As Represented By The Department Of Health And Human Services Amperometric biomimetic enzyme sensors based on modified cyclodextrin as electrocatalysts
DE60028991T2 (en) * 1999-10-07 2007-02-08 Pepex Biomedical, LLC, Alameda A sensor comprising an insulating sheath containing therein a plurality of conductive fibers at least partially surrounded by a sensitive material and containing voids between the fibers
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
EP1366354A2 (en) * 2001-03-07 2003-12-03 Instrumentation Laboratory Company Reference electrode
US6872297B2 (en) * 2001-05-31 2005-03-29 Instrumentation Laboratory Company Analytical instruments, biosensors and methods thereof
US6652720B1 (en) 2001-05-31 2003-11-25 Instrumentation Laboratory Company Analytical instruments, biosensors and methods thereof
US20030032874A1 (en) 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US7192766B2 (en) * 2001-10-23 2007-03-20 Medtronic Minimed, Inc. Sensor containing molded solidified protein
US7379765B2 (en) 2003-07-25 2008-05-27 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8858434B2 (en) 2004-07-13 2014-10-14 Dexcom, Inc. Transcutaneous analyte sensor
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7613491B2 (en) 2002-05-22 2009-11-03 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US7422903B2 (en) * 2002-12-11 2008-09-09 Instrumentation Laboratory Company Multi-analyte reference solutions
US20040154933A1 (en) * 2003-02-11 2004-08-12 Instrumentation Laboratory Company Polymeric membranes for use in electrochemical sensors
US20040256227A1 (en) * 2003-02-11 2004-12-23 Jungwon Shin Electrochemical urea sensors and methods of making the same
US7875293B2 (en) * 2003-05-21 2011-01-25 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
JP4839569B2 (en) * 2003-06-05 2011-12-21 ソニー株式会社 Enzyme-immobilized electrode and manufacturing method thereof, electrode reaction utilization apparatus and manufacturing method thereof
WO2007120442A2 (en) * 2003-07-25 2007-10-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
JP2007500336A (en) 2003-07-25 2007-01-11 デックスコム・インコーポレーテッド Electrode system for electrochemical sensors
US20100168657A1 (en) 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US6931327B2 (en) 2003-08-01 2005-08-16 Dexcom, Inc. System and methods for processing analyte sensor data
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
JP4431147B2 (en) * 2003-11-28 2010-03-10 ラジオメーター・メディカル・アー・ペー・エス Reference solution
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
EP1711790B1 (en) 2003-12-05 2010-09-08 DexCom, Inc. Calibration techniques for a continuous analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8532730B2 (en) 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US8277713B2 (en) 2004-05-03 2012-10-02 Dexcom, Inc. Implantable analyte sensor
US8028323B2 (en) 2004-05-05 2011-09-27 Dryden Enterprises, Llc Method and system for employing a first device to direct a networked audio device to obtain a media item
US8028038B2 (en) 2004-05-05 2011-09-27 Dryden Enterprises, Llc Obtaining a playlist based on user profile matching
US20080242961A1 (en) * 2004-07-13 2008-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US20060270922A1 (en) * 2004-07-13 2006-11-30 Brauker James H Analyte sensor
US7905833B2 (en) 2004-07-13 2011-03-15 Dexcom, Inc. Transcutaneous analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US20090076360A1 (en) 2007-09-13 2009-03-19 Dexcom, Inc. Transcutaneous analyte sensor
US8744546B2 (en) 2005-05-05 2014-06-03 Dexcom, Inc. Cellulosic-based resistance domain for an analyte sensor
US8060174B2 (en) 2005-04-15 2011-11-15 Dexcom, Inc. Analyte sensing biointerface
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
WO2007120381A2 (en) 2006-04-14 2007-10-25 Dexcom, Inc. Analyte sensor
US20070287991A1 (en) * 2006-06-08 2007-12-13 Mckay William F Devices and methods for detection of markers of axial pain with or without radiculopathy
US7831287B2 (en) * 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US20090247856A1 (en) * 2008-03-28 2009-10-01 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8583204B2 (en) 2008-03-28 2013-11-12 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8682408B2 (en) 2008-03-28 2014-03-25 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US11730407B2 (en) 2008-03-28 2023-08-22 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8560039B2 (en) 2008-09-19 2013-10-15 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
WO2012142502A2 (en) 2011-04-15 2012-10-18 Dexcom Inc. Advanced analyte sensor calibration and error detection
WO2012159040A2 (en) 2011-05-19 2012-11-22 Pepex Biomedical Inc. Fluid management and patient monitoring system
WO2013120184A1 (en) * 2012-02-17 2013-08-22 Micropharma Limited Ingestible medical device
EP3320333B1 (en) * 2015-07-06 2023-08-09 Radiometer Medical ApS Method for correcting crea sensor for calcium inhibition
US10202567B2 (en) * 2016-01-21 2019-02-12 Lawrence Livermore National Security, Llc Bioreactors including enzyme-embedded multicomponent polymers
EP3619531A4 (en) 2017-05-04 2020-05-06 Siemens Healthcare Diagnostics Inc. Biosensors produced from enzymes with reduced solubility and methods of production and use thereof
WO2020041454A1 (en) 2018-08-21 2020-02-27 Lonza Ltd A process for creating reference data for predicting concentrations of quality attributes
CN116359311A (en) * 2023-02-15 2023-06-30 重庆联芯致康生物科技有限公司 Dynamic lactic acid sensor film and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD244567A1 (en) * 1985-12-23 1987-04-08 Akad Wissenschaften Ddr METHOD FOR INCREASING THE SPECIFICITY OF HOEHER INTEGRATED BIOLOGICALLY ACTIVE SYSTEMS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211402D0 (en) * 1992-05-29 1992-07-15 Univ Manchester Sensor devices
GB9215973D0 (en) * 1992-07-28 1992-09-09 Univ Manchester Sensor devices

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD244567A1 (en) * 1985-12-23 1987-04-08 Akad Wissenschaften Ddr METHOD FOR INCREASING THE SPECIFICITY OF HOEHER INTEGRATED BIOLOGICALLY ACTIVE SYSTEMS

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOSENSORS & BIOELECTRONICS, Volume 12, No. 5, 1997, A.L. SIMONIAN et al., "A Tryptophan-2-Monooxygenase Based Amperometric Biosensor for L-Tryptophan Determination: Use of a Competitive Inhibitor as a Tool for Selectivity Increase", pages 363-371. *
BIOSENSORS, Volume 4, 1989, MAKOTO DEMURA et al., "Immobilization of Biocatalysts with Bombyx Mori Silk Fibroin by Several Kinds of Physical Treatment and Its Application to Glucose Sensors", pages 361-372. *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2261647A1 (en) * 2001-05-31 2010-12-15 Instrumentation Laboratory Company Cross-linked enzyme matrix and uses thereof
US8426192B2 (en) 2001-05-31 2013-04-23 Instrumentation Laboratory Company Composite membrane containing a cross-linked enzyme matrix for a biosensor
US9388503B2 (en) 2001-05-31 2016-07-12 Instrumentation Laboratory Company Cross-linked enzyme matrix and uses thereof
WO2006122552A1 (en) 2005-05-17 2006-11-23 Radiometer Medical Aps Method of stabilising or reactivating a creatinine sensor with a solution of a divalent manganese ion
WO2006122554A2 (en) 2005-05-17 2006-11-23 Radiometer Medical Aps Enzyme sensor with a cover membrane layer covered by a hydrophilic polymer
CN104198556A (en) * 2014-08-11 2014-12-10 南京普朗医疗设备有限公司 Preparation method of electrode membrane based on lactate oxidase and product prepared by the method
WO2020204975A1 (en) * 2019-04-05 2020-10-08 Instrumentation Laboratory Company Multi-enzymatic biosensors and stabilization of multi-enzymatic biosensors at room temperature
KR20210014666A (en) * 2019-04-05 2021-02-09 인스트루멘테이션 래보라토리 컴퍼니 Stabilization of multi-enzyme biosensors and multi-enzyme biosensors at room temperature
CN112424369A (en) * 2019-04-05 2021-02-26 仪器实验室公司 Multi-enzyme biosensor and stabilization of multi-enzyme biosensor at room temperature
AU2019440163B2 (en) * 2019-04-05 2022-01-27 Instrumentation Laboratory Company Multi-enzymatic biosensors and stabilization of multi-enzymatic biosensors at room temperature
US11293890B2 (en) 2019-04-05 2022-04-05 Instrumentation Laboratory Company Multi-enzymatic biosensors and stabilization of multi-enzymatic biosensors at room temperature
US11327042B2 (en) 2019-04-05 2022-05-10 Instrumentation Laboratory Company Compositions and methods for improved creatinine measurement accuracy and uses thereof
US11460431B2 (en) 2019-04-05 2022-10-04 Instrumentation Laboratory Company Urea biosensors and stabilization of urea biosensors at room temperature
KR102519408B1 (en) * 2019-04-05 2023-04-10 인스트루멘테이션 래보라토리 컴퍼니 Multienzyme biosensors and stabilization of multienzyme biosensors at room temperature
US11761921B2 (en) 2019-04-05 2023-09-19 Instrumentation Laboratory Company Outer membrane compositions for creatinine/creatine sensors

Also Published As

Publication number Publication date
EP0944731B1 (en) 2006-01-18
JP2000507457A (en) 2000-06-20
US6051389A (en) 2000-04-18
ATE316147T1 (en) 2006-02-15
DK0944731T3 (en) 2006-05-22
DE69735127D1 (en) 2006-04-06
DE69735127T2 (en) 2006-08-31
EP0944731A1 (en) 1999-09-29

Similar Documents

Publication Publication Date Title
EP0944731B1 (en) Enzyme sensor
US4240889A (en) Enzyme electrode provided with immobilized enzyme membrane
CN101184851B (en) Enzyme sensor including a water-containing spacer layer
US5411866A (en) Method and system for determining bioactive substances
Emr et al. Use of polymer films in amperometric biosensors
EP0856064B1 (en) Soybean peroxidase electrochemical sensor
US20060275859A1 (en) Enzyme sensor including a water-containing spacer layer
EP1235068B1 (en) Biosensor
US4886740A (en) Enzyme-electrode sensor with organosilane treated membrane
Doretti et al. PEG-modified glucose oxidase immobilized on a PVA cryogel membrane for amperometric biosensor applications
Mascini et al. Amperometric acetylcholine and choline sensors with immobilized enzymes
Mizutani et al. Amperometric determination of pyruvate, phosphate and urea using enzyme electrodes based on pyruvate oxidase-containing poly (vinyl alcohol)/polyion complex-bilayer membrane
EP1885870A1 (en) Enzyme sensor including a water-containing spacer layer
JPH0761280B2 (en) Simultaneous measurement of glucose and 1,5-anhydroglucitol
Bardeletti et al. Amperometric enzyme electrodes for substrate and enzyme activity determinations
Murtinho et al. Cellulose derivatives membranes as supports for immobilisation of enzymes
EP1889075B1 (en) Method of stabilising or reactivating a creatinine sensor with a solution of a divalent manganese ion
Campanella et al. Enzyme-entrapping membranes for enzyme sensors
Pundir et al. Immobilization of Arthrobacter sarcosine oxidase onto alkylamine and arylamine glass and its application in serum sarcosine determination
Liu et al. Polymers and enzyme biosensors
Popp et al. Sandwich enzyme membranes for amperometric multi-biosensor applications: improvement of linearity and reduction of chemical cross-talk
JPH02236153A (en) Permselective membrane and electrode using the same
Zhu et al. Microbial enzymatic assay of glucose in serum
Beesabathuni Evaluation of immobilizing horseradish peroxidase and alcohol oxidase in PVA-AWP polymer
Yoda [5] Multienzyme membrane electrodes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997912066

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 522060

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09308212

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1997912066

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1997912066

Country of ref document: EP